Credit Agricole S A Eagle Pharmaceuticals, Inc. Transaction History
Credit Agricole S A
- $33.2 Billion
- Q4 2024
A detailed history of Credit Agricole S A transactions in Eagle Pharmaceuticals, Inc. stock. As of the latest transaction made, Credit Agricole S A holds 36 shares of EGRX stock, worth $41. This represents 0.0% of its overall portfolio holdings.
Number of Shares
36
Previous 36
-0.0%
Holding current value
$41
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding EGRX
# of Institutions
15Shares Held
498KCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY353KShares$409,2030.0% of portfolio
-
Ajo Vista, LLC Boston, MA56.4KShares$65,4680.92% of portfolio
-
Xtx Topco LTD London, X023.6KShares$27,3690.0% of portfolio
-
Simplex Trading, LLC18.2KShares$21,0670.0% of portfolio
-
Barclays PLC London, X014.2KShares$16,5100.0% of portfolio
About EAGLE PHARMACEUTICALS, INC.
- Ticker EGRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 13,015,900
- Market Cap $15.1M
- Description
- Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and in...